\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\ reveals\\ a\\ mildly\\ swollen\\ right\\ upper\\ extremity\\ but\\ is\\ otherwise\\ normal\\.\ \(0\)\
\-\ medical\\ anticoagulation\\,\\ catheter\\ directed\\ thrombolysis\\,\\ thrombectomy\\,\\ ballon\\ angioplasty\\ and\\ stent\\ placement\\ were\\ not\\ viable\\ considerations\\ given\\ the\\ chronicity\\ of\\ the\\ occlusion\\.\\ \\ the\\ patient\\ was\\ offered\\ surgical\\ decompression\\ as\\ the\\ primary\\ therapeutic\\ option\\.\ \(0\)\
\-\ right\\ upper\\ extremity\\ venogram\\ demonstrates\\ a\\ short\\ segment\\ occlusion\\ of\\ the\\ right\\ axillary\\ vein\\ with\\ multiple\\ dilated\\ and\\ well\\-defined\\ collateral\\ vessels\\.\ \(0\)\
\-\ venous\\ thoracic\\ outlet\\ syndrome\ \(1\)\
\-\ pancoast\\ tumer\ \(0\)\
\-\ acute\\ upper\\ extremity\\ venous\\ thrombosis\ \(0\)\
\-\ venous\\ thoracic\\ outlet\\ syndrome\\(paget\\-schroetter\\ disease\\)\ \(0\)\
\-\ 28\\ y\\.o\\.\\ active\\ duty\\ male\\ with\\ two\\ year\\ history\\ of\\ progressive\\ upper\\ extremity\\ pain\\ and\\ swelling\\,\\ not\\ related\\ to\\ any\\ certain\\ activity\\.\ \(0\)\
\-\ venous\\ thoracic\\ outlet\\ syndrome\\ is\\ an\\ uncommon\\ cause\\ of\\ upper\\ extremity\\ deep\\ venous\\ thrombosis\\.\\ this\\ syndrome\\ can\\ be\\ categorized\\ into\\ two\\ types\\ based\\ on\\ etiology\\:\\ primary\\ venous\\ thoracic\\ outlet\\ syndrome\\ \\(paget\\ \\â\\€\\“\\ schroetters\\ disease\\)\\ or\\ secondary\\ venous\\ thoracic\\ outlet\\ syndrome\\.\ \(0\)\
\-\ the\\ causes\\ of\\ primary\\ venous\\ thrombosis\\ are\\ most\\ likely\\ multi\\-factorial\\,\\ and\\ include\\ vein\\ compression\\ by\\ various\\ anatomic\\ anomalies\\;\\ such\\ as\\ cervical\\ ribs\\,\\ hypertrophied\\ subclavius\\ muscles\\ and\\ prominent\\ costoclavicular\\ ligaments\\.\ \(0\)\
\-\ \\ \ \(1082074\)\
\-\ the\\ causes\\ of\\ secondary\\ venous\\ thrombosis\\ are\\ many\\,\\ and\\ include\\:\\ central\\ venous\\ catheters\\ \\(most\\ common\\)\\,\\ venous\\ foreign\\ bodies\\,\\ trauma\\,\\ external\\ compression\\ from\\ tumors\\ or\\ lymphadenopathy\\,\\ neck\\ infections\\,\\ fibrosing\\ mediastinitis\\,\\ and\\ radiation\\ therapy\\.\ \(0\)\
\-\ with\\ continuing\\ irritation\\ of\\ the\\ vessel\\ walls\\,\\ there\\ is\\ an\\ increased\\ likelihood\\ of\\ venous\\ stasis\\ formation\\,\\ intimal\\ injury\\,\\ and\\ hypercoagulability\\ \\(i\\.e\\.\\ \\â\\€\\“\\ virchow\\â\\€\\™s\\ triad\\)\\,\\ which\\ subsequently\\ leads\\ to\\ thrombus\\ formation\\ and\\ eventually\\ lumen\\ occlusion\\.\ \(0\)\
\-\ primary\\ venous\\ thoracic\\ outlet\\ syndrome\\ is\\ historically\\ seen\\ in\\ the\\ young\\ male\\ population\\,\\ with\\ the\\ right\\ upper\\ extremity\\ more\\ often\\ affected\\ than\\ the\\ left\\.\\ \\ the\\ patient\\ will\\ usually\\ complain\\ of\\ sudden\\ onset\\ arm\\ pain\\ and\\ swelling\\ associated\\ with\\ vigorous\\ exercise\\.\\ \ \(0\)\
\-\ unlike\\ its\\ counterpart\\,\\ secondary\\ venous\\ thrombosis\\ most\\ often\\ affects\\ older\\ patients\\ and\\ has\\ a\\ more\\ uniform\\ sex\\ distribution\\.\\ reported\\ symptoms\\ include\\:\\ swelling\\,\\ discoloration\\,\\ collateral\\ vein\\ dilatation\\,\\ and\\ aching\\.\\ patients\\ with\\ secondary\\ venous\\ thrombosis\\ may\\ have\\ a\\ delay\\ in\\ clinical\\ presentation\\,\\ which\\ leads\\ in\\ turn\\,\\ to\\ delayed\\ treatment\\.\ \(0\)\
\-\ classic\\ findings\\ of\\ venous\\ thoracic\\ outlet\\ syndrome\\ on\\ venography\\ include\\ short\\-segment\\ occlusions\\ involving\\ either\\ the\\ axillary\\ or\\ subclavian\\ veins\\,\\ and\\ multiple\\ well\\-defined\\ venous\\ collaterals\\.\ \(0\)\
\-\ treatment\\ options\\ for\\ both\\ categories\\ of\\ venous\\ thoracic\\ outlet\\ syndrome\\ usually\\ involve\\ an\\ integrated\\ approach\\,\\ which\\ combines\\ conservative\\ modalities\\ such\\ as\\ bed\\ rest\\,\\ arm\\ elevation\\ and\\ medical\\ anticoagulation\\,\\ with\\ catheter\\ directed\\ thrombolysis\\,\\ thrombectomy\\,\\ balloon\\ angioplasty\\ and\\ surgical\\ decompression\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ venous\\:\\ 0\\.1235224361332485\ \(0\)\
\-\ outlet\\:\\ 0\\.09704980378391671\ \(0\)\
\-\ thoracic\\:\\ 0\\.05830190276290711\ \(0\)\
\-\ thrombosis\\:\\ 0\\.04869058336928821\ \(0\)\
\-\ syndrome\\:\\ 0\\.04866185661639773\ \(0\)\
\-\ extremity\\:\\ 0\\.041484411101448286\ \(0\)\
\-\ thrombectomy\\:\\ 0\\.028396562615788174\ \(0\)\
\-\ occlusion\\:\\ 0\\.028285231409508567\ \(0\)\
\-\ upper\\:\\ 0\\.02737275007126617\ \(0\)\
\-\ thrombolysis\\:\\ 0\\.02673862699879078\ \(0\)\
\-\ angioplasty\\:\\ 0\\.02426245094597918\ \(0\)\
\-\ directed\\:\\ 0\\.02257498388169111\ \(0\)\
\-\ primary\\:\\ 0\\.022401630645094657\ \(0\)\
\-\ include\\:\\ 0\\.021213747681683954\ \(0\)\
\-\ secondary\\:\\ 0\\.021141858110697413\ \(0\)\
\-\ leads\\:\\ 0\\.021117111310318355\ \(0\)\
\-\ axillary\\:\\ 0\\.020535978557835666\ \(0\)\
\-\ vein\\:\\ 0\\.02052168134080166\ \(0\)\
\-\ decompression\\:\\ 0\\.02002238487972614\ \(0\)\
\-\ collateral\\:\\ 0\\.019786340717313337\ \(0\)\
\-\ tumer\\:\\ 0\\.019503359345058625\ \(0\)\
\-\ paget\\-schroetter\\:\\ 0\\.019503359345058625\ \(0\)\
\-\ schroetters\\:\\ 0\\.019503359345058625\ \(0\)\
\-\ multi\\-factorial\\:\\ 0\\.019503359345058625\ \(0\)\
\-\ subclavius\\:\\ 0\\.019503359345058625\ \(0\)\
\-\ counterpart\\:\\ 0\\.019503359345058625\ \(0\)\
\-\ well\\-defined\\:\\ 0\\.019454326620220796\ \(0\)\
\-\ anticoagulation\\:\\ 0\\.01909605643201873\ \(0\)\
\-\ swelling\\:\\ 0\\.018894762371556188\ \(0\)\
\-\ catheter\\:\\ 0\\.01816808948077064\ \(0\)\
\-\ short\\-segment\\:\\ 0\\.017969847883642816\ \(0\)\
\-\ combines\\:\\ 0\\.017969847883642816\ \(0\)\
\-\ \\,\\:\\ 0\\.01796748222459872\ \(0\)\
\-\ costoclavicular\\:\\ 0\\.01707280118428847\ \(0\)\
\-\ \\â\\€\\“\\:\\ 0\\.017016394355710167\ \(0\)\
\-\ ballon\\:\\ 0\\.016436336422227006\ \(0\)\
\-\ pancoast\\:\\ 0\\.016436336422227006\ \(0\)\
\-\ occlusions\\:\\ 0\\.016436336422227006\ \(0\)\
\-\ arm\\:\\ 0\\.015836621509453756\ \(0\)\
\-\ formation\\:\\ 0\\.015607307049875943\ \(0\)\
\-\ historically\\:\\ 0\\.01553928972287266\ \(0\)\
\-\ virchow\\:\\ 0\\.015198248395821205\ \(0\)\
\-\ integrated\\:\\ 0\\.015198248395821205\ \(0\)\
\-\ aching\\:\\ 0\\.0149028249608112\ \(0\)\
\-\ venography\\:\\ 0\\.0149028249608112\ \(0\)\
\-\ causes\\:\\ 0\\.014719383618627485\ \(0\)\
\-\ hypercoagulability\\:\\ 0\\.014642243023518315\ \(0\)\
\-\ vigorous\\:\\ 0\\.014642243023518315\ \(0\)\
\-\ chronicity\\:\\ 0\\.014409144537549674\ \(0\)\
\-\ fibrosing\\:\\ 0\\.014409144537549674\ \(0\)\
\-\ discoloration\\:\\ 0\\.014198281307894087\ \(0\)\
\-\ compression\\:\\ 0\\.014153749231415604\ \(0\)\
\-\ categorized\\:\\ 0\\.014005778261456853\ \(0\)\
\-\ mediastinitis\\:\\ 0\\.013664736934405397\ \(0\)\
\-\ catheters\\:\\ 0\\.01336931349939539\ \(0\)\
\-\ intimal\\:\\ 0\\.01336931349939539\ \(0\)\
\-\ viable\\:\\ 0\\.013235188229890005\ \(0\)\
\-\ venogram\\:\\ 0\\.013235188229890005\ \(0\)\
\-\ sex\\:\\ 0\\.013235188229890005\ \(0\)\
\-\ collaterals\\:\\ 0\\.013235188229890005\ \(0\)\
\-\ most\\:\\ 0\\.01309403855129254\ \(0\)\
\-\ offered\\:\\ 0\\.012875633076133866\ \(0\)\
\-\ categories\\:\\ 0\\.012875633076133866\ \(0\)\
\-\ irritation\\:\\ 0\\.01276769023505105\ \(0\)\
\-\ stasis\\:\\ 0\\.01276769023505105\ \(0\)\
\-\ triad\\:\\ 0\\.01276769023505105\ \(0\)\
\-\ continuing\\:\\ 0\\.01266476984647828\ \(0\)\
\-\ turn\\:\\ 0\\.01266476984647828\ \(0\)\
\-\ certain\\:\\ 0\\.01213122547298959\ \(0\)\
\-\ often\\:\\ 0\\.012064042250086957\ \(0\)\
\-\ hypertrophied\\:\\ 0\\.012053589809690318\ \(0\)\
\-\ unlike\\:\\ 0\\.011906042520976443\ \(0\)\
\-\ complain\\:\\ 0\\.011835802037979582\ \(0\)\
\-\ such\\:\\ 0\\.01182005659221616\ \(0\)\
\-\ likelihood\\:\\ 0\\.011767723147123932\ \(0\)\
\-\ medical\\:\\ 0\\.01163411415958409\ \(0\)\
\-\ usually\\:\\ 0\\.011481983424189199\ \(0\)\
\-\ modalities\\:\\ 0\\.011342121614718056\ \(0\)\
\-\ balloon\\:\\ 0\\.011131258385062471\ \(0\)\
\-\ uniform\\:\\ 0\\.011081539677425175\ \(0\)\
\-\ bed\\:\\ 0\\.010985333677558495\ \(0\)\
\-\ considerations\\:\\ 0\\.010893137446583786\ \(0\)\
\-\ two\\:\\ 0\\.01082889928148675\ \(0\)\
\-\ affects\\:\\ 0\\.01076166970217936\ \(0\)\
\-\ stent\\:\\ 0\\.010637577961800945\ \(0\)\
\-\ therapeutic\\:\\ 0\\.010637577961800945\ \(0\)\
\-\ which\\:\\ 0\\.010587242835680633\ \(0\)\
\-\ option\\:\\ 0\\.010558555655159178\ \(0\)\
\-\ ligaments\\:\\ 0\\.010558555655159178\ \(0\)\
\-\ paget\\:\\ 0\\.0104822588054442\ \(0\)\
\-\ various\\:\\ 0\\.010445074915363712\ \(0\)\
\-\ eventually\\:\\ 0\\.010408505663259264\ \(0\)\
\-\ ribs\\:\\ 0\\.01020094204552109\ \(0\)\
\-\ i\\.e\\:\\ 0\\.010104033588312255\ \(0\)\
\-\ swollen\\:\\ 0\\.010072651652489342\ \(0\)\
\-\ approach\\:\\ 0\\.009922090893097715\ \(0\)\
\-\ anomalies\\:\\ 0\\.009893170358656668\ \(0\)\
\-\ duty\\:\\ 0\\.009864623002825014\ \(0\)\
\-\ population\\:\\ 0\\.009864623002825014\ \(0\)\
\-\ patients\\:\\ 0\\.009785728315778876\ \(0\)\
\-\ exercise\\:\\ 0\\.009700667312219434\ \(0\)\
\-\ types\\:\\ 0\\.009648608689630508\ \(0\)\
\-\ walls\\:\\ 0\\.009648608689630508\ \(0\)\
\-\ subclavian\\:\\ 0\\.009648608689630508\ \(0\)\
\-\ anatomic\\:\\ 0\\.009548028216009365\ \(0\)\
\-\ thrombus\\:\\ 0\\.009548028216009365\ \(0\)\
\-\ older\\:\\ 0\\.009523581675773558\ \(0\)\
\-\ more\\:\\ 0\\.009456532342089232\ \(0\)\
\-\ delay\\:\\ 0\\.009382317357219281\ \(0\)\
\-\ elevation\\:\\ 0\\.00933716498635378\ \(0\)\
\-\ foreign\\:\\ 0\\.009314929730040722\ \(0\)\
\-\ uncommon\\:\\ 0\\.009249534149860315\ \(0\)\
\-\ options\\:\\ 0\\.009186016216492105\ \(0\)\
\-\ lumen\\:\\ 0\\.009104066500385137\ \(0\)\
\-\ veins\\:\\ 0\\.009044536737287959\ \(0\)\
\-\ vessel\\:\\ 0\\.00900572189292754\ \(0\)\
\-\ infections\\:\\ 0\\.008986566886858702\ \(0\)\
\-\ short\\:\\ 0\\.008911563453947904\ \(0\)\
\-\ 28\\:\\ 0\\.008911563453947904\ \(0\)\
\-\ involve\\:\\ 0\\.008911563453947904\ \(0\)\
\-\ bodies\\:\\ 0\\.0088569337800754\ \(0\)\
\-\ sudden\\:\\ 0\\.008734477817502025\ \(0\)\
\-\ rest\\:\\ 0\\.00871752455921537\ \(0\)\
\-\ muscles\\:\\ 0\\.008634653845642581\ \(0\)\
\-\ as\\:\\ 0\\.00857905424266014\ \(0\)\
\-\ subsequently\\:\\ 0\\.008570522126896447\ \(0\)\
\-\ distribution\\:\\ 0\\.008508197177855083\ \(0\)\
\-\ segment\\:\\ 0\\.0082476152405622\ \(0\)\
\-\ young\\:\\ 0\\.00823400049371623\ \(0\)\
\-\ either\\:\\ 0\\.00823400049371623\ \(0\)\
\-\ affected\\:\\ 0\\.008180364184844564\ \(0\)\
\-\ dilatation\\:\\ 0\\.00810227174661221\ \(0\)\
\-\ mildly\\:\\ 0\\.008051700644674047\ \(0\)\
\-\ external\\:\\ 0\\.00803923644618233\ \(0\)\
\-\ lymphadenopathy\\:\\ 0\\.00803923644618233\ \(0\)\
\-\ etiology\\:\\ 0\\.00800225971836432\ \(0\)\
\-\ right\\:\\ 0\\.00797904167354351\ \(0\)\
\-\ multiple\\:\\ 0\\.007963743378226853\ \(0\)\
\-\ surgical\\:\\ 0\\.007947883939165724\ \(0\)\
\-\ an\\:\\ 0\\.007842908391270331\ \(0\)\
\-\ related\\:\\ 0\\.007803653524937971\ \(0\)\
\-\ many\\:\\ 0\\.0077703838847509345\ \(0\)\
\-\ prominent\\:\\ 0\\.007759404262312595\ \(0\)\
\-\ delayed\\:\\ 0\\.007694646779347743\ \(0\)\
\-\ placement\\:\\ 0\\.007673475427542101\ \(0\)\
\-\ treatment\\:\\ 0\\.007653172387614544\ \(0\)\
\-\ deep\\:\\ 0\\.007652504755076295\ \(0\)\
\-\ vessels\\:\\ 0\\.007611150478500737\ \(0\)\
\-\ conservative\\:\\ 0\\.00755053327896951\ \(0\)\
\-\ \\:\\:\\ 0\\.0075018239999380424\ \(0\)\
\-\ progressive\\:\\ 0\\.007472210431511732\ \(0\)\
\-\ reveals\\:\\ 0\\.007396565819236777\ \(0\)\
\-\ classic\\:\\ 0\\.007243926723026708\ \(0\)\
\-\ active\\:\\ 0\\.007218050528860355\ \(0\)\
\-\ based\\:\\ 0\\.007209491951918054\ \(0\)\
\-\ its\\:\\ 0\\.007133919122689472\ \(0\)\
\-\ tumors\\:\\ 0\\.007101142384226772\ \(0\)\
\-\ activity\\:\\ 0\\.007093023515003404\ \(0\)\
\-\ reported\\:\\ 0\\.006891758518973035\ \(0\)\
\-\ dilated\\:\\ 0\\.006869671253521302\ \(0\)\
\-\ cervical\\:\\ 0\\.006869671253521302\ \(0\)\
\-\ male\\:\\ 0\\.006837192645519793\ \(0\)\
\-\ otherwise\\:\\ 0\\.0067905204279343915\ \(0\)\
\-\ or\\:\\ 0\\.006647274882502483\ \(0\)\
\-\ involving\\:\\ 0\\.006633644389387818\ \(0\)\
\-\ presentation\\:\\ 0\\.0065119483063962\ \(0\)\
\-\ given\\:\\ 0\\.006481005293177749\ \(0\)\
\-\ cause\\:\\ 0\\.006396598731309659\ \(0\)\
\-\ \\(\\:\\ 0\\.006392581648175757\ \(0\)\
\-\ \\)\\:\\ 0\\.006314492850560222\ \(0\)\
\-\ central\\:\\ 0\\.006220423355884865\ \(0\)\
\-\ radiation\\:\\ 0\\.006204095684872426\ \(0\)\
\-\ disease\\:\\ 0\\.0061802546071491335\ \(0\)\
\-\ injury\\:\\ 0\\.0060270100484265485\ \(0\)\
\-\ and\\:\\ 0\\.005973750190228489\ \(0\)\
\-\ onset\\:\\ 0\\.005967746075055642\ \(0\)\
\-\ any\\:\\ 0\\.005953174851929853\ \(0\)\
\-\ will\\:\\ 0\\.005914781014113146\ \(0\)\
\-\ clinical\\:\\ 0\\.005817057079792045\ \(0\)\
\-\ \\â\\€\\™\\:\\ 0\\.005650501636383752\ \(0\)\
\-\ neck\\:\\ 0\\.005551422869509917\ \(0\)\
\-\ not\\:\\ 0\\.00546379943248644\ \(0\)\
\-\ y\\.o\\:\\ 0\\.005456591665014823\ \(0\)\
\-\ s\\:\\ 0\\.00542205236087298\ \(0\)\
\-\ likely\\:\\ 0\\.005332499924636408\ \(0\)\
\-\ trauma\\:\\ 0\\.00517037341096887\ \(0\)\
\-\ are\\:\\ 0\\.005154309170484963\ \(0\)\
\-\ therapy\\:\\ 0\\.00505451503593056\ \(0\)\
\-\ is\\:\\ 0\\.004976024587475448\ \(0\)\
\-\ than\\:\\ 0\\.004953647909111225\ \(0\)\
\-\ common\\:\\ 0\\.00494749383176194\ \(0\)\
\-\ both\\:\\ 0\\.004827876085588764\ \(0\)\
\-\ symptoms\\:\\ 0\\.00471163158605783\ \(0\)\
\-\ acute\\:\\ 0\\.004667874621917025\ \(0\)\
\-\ physical\\:\\ 0\\.004638285994648757\ \(0\)\
\-\ increased\\:\\ 0\\.004624966331415167\ \(0\)\
\-\ pain\\:\\ 0\\.004617735254560773\ \(0\)\
\-\ into\\:\\ 0\\.00449850966362767\ \(0\)\
\-\ \\;\\:\\ 0\\.004481020328434942\ \(0\)\
\-\ associated\\:\\ 0\\.00446120035820288\ \(0\)\
\-\ were\\:\\ 0\\.004292668886482127\ \(0\)\
\-\ can\\:\\ 0\\.004288102549710331\ \(0\)\
\-\ exam\\:\\ 0\\.0041531724335166775\ \(0\)\
\-\ may\\:\\ 0\\.00414674417897815\ \(0\)\
\-\ demonstrates\\:\\ 0\\.004129692924011473\ \(0\)\
\-\ have\\:\\ 0\\.00409388955390507\ \(0\)\
\-\ but\\:\\ 0\\.004032086949189243\ \(0\)\
\-\ findings\\:\\ 0\\.004023975521659203\ \(0\)\
\-\ the\\:\\ 0\\.003976196241475963\ \(0\)\
\-\ patient\\:\\ 0\\.003790229782815876\ \(0\)\
\-\ seen\\:\\ 0\\.0037359018032471023\ \(0\)\
\-\ has\\:\\ 0\\.003550221173659907\ \(0\)\
\-\ a\\:\\ 0\\.0035097327594566484\ \(0\)\
\-\ on\\:\\ 0\\.003203057576838177\ \(0\)\
\-\ by\\:\\ 0\\.003147944476205475\ \(0\)\
\-\ normal\\:\\ 0\\.002963744368582082\ \(0\)\
\-\ be\\:\\ 0\\.0029153909808494007\ \(0\)\
\-\ of\\:\\ 0\\.002835269488446621\ \(0\)\
\-\ to\\:\\ 0\\.0028345228436481387\ \(0\)\
\-\ there\\:\\ 0\\.0028135299921791786\ \(0\)\
\-\ from\\:\\ 0\\.0028018489229075494\ \(0\)\
\-\ in\\:\\ 0\\.0027968842708424\ \(0\)\
\-\ history\\:\\ 0\\.0026110941099714235\ \(0\)\
\-\ was\\:\\ 0\\.002186454695163024\ \(0\)\
\-\ this\\:\\ 0\\.002126409763969321\ \(0\)\
\-\ year\\:\\ 0\\.002115277144409103\ \(0\)\
\-\ left\\:\\ 0\\.002115277144409103\ \(0\)\
\-\ with\\:\\ 0\\.0018120115766133366\ \(0\)\
\-\ for\\:\\ 0\\.0016130711253157413\ \(0\)\
\-\ \\.\\:\\ 0\\.0014922371368353523\ \(0\)\
